Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Closure Devices | 1 | 2019 | 5 | 0.670 |
Why?
|
| Hemostatic Techniques | 1 | 2019 | 14 | 0.670 |
Why?
|
| Aortic Diseases | 1 | 2019 | 16 | 0.660 |
Why?
|
| Vascular Surgical Procedures | 2 | 2017 | 54 | 0.660 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 24 | 0.650 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 60 | 0.640 |
Why?
|
| Carotid Artery, External | 1 | 2017 | 4 | 0.590 |
Why?
|
| Thoracic Wall | 1 | 2017 | 11 | 0.590 |
Why?
|
| Mammary Arteries | 1 | 2017 | 6 | 0.580 |
Why?
|
| Skin Transplantation | 1 | 2017 | 14 | 0.580 |
Why?
|
| Subclavian Artery | 1 | 2017 | 14 | 0.580 |
Why?
|
| Hemorrhage | 1 | 2019 | 259 | 0.580 |
Why?
|
| Arteriovenous Malformations | 1 | 2017 | 16 | 0.580 |
Why?
|
| Embolization, Therapeutic | 1 | 2017 | 45 | 0.570 |
Why?
|
| Treatment Outcome | 4 | 2019 | 2264 | 0.240 |
Why?
|
| Punctures | 1 | 2019 | 17 | 0.170 |
Why?
|
| Vascular System Injuries | 1 | 2019 | 13 | 0.170 |
Why?
|
| Hematoma | 1 | 2019 | 26 | 0.170 |
Why?
|
| Blood Transfusion | 1 | 2019 | 73 | 0.160 |
Why?
|
| Equipment Design | 1 | 2019 | 211 | 0.160 |
Why?
|
| Length of Stay | 1 | 2019 | 215 | 0.150 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 18 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 24 | 0.150 |
Why?
|
| Time Factors | 2 | 2019 | 1562 | 0.140 |
Why?
|
| Erythrocytes | 1 | 1996 | 83 | 0.130 |
Why?
|
| Risk Factors | 2 | 2019 | 2011 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 1996 | 151 | 0.130 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2015 | 3 | 0.120 |
Why?
|
| Splanchnic Circulation | 1 | 2015 | 7 | 0.120 |
Why?
|
| Celiac Artery | 1 | 2015 | 5 | 0.120 |
Why?
|
| Neurons | 1 | 1996 | 275 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2015 | 67 | 0.120 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2013 | 4 | 0.110 |
Why?
|
| Vertebral Artery | 1 | 2013 | 16 | 0.110 |
Why?
|
| Angioplasty, Balloon | 1 | 2013 | 21 | 0.110 |
Why?
|
| Humans | 5 | 2019 | 26827 | 0.090 |
Why?
|
| Middle Aged | 2 | 2017 | 6818 | 0.080 |
Why?
|
| Male | 3 | 2017 | 12870 | 0.070 |
Why?
|
| Radiography | 2 | 2015 | 200 | 0.060 |
Why?
|
| Calcineurin | 1 | 2000 | 7 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 243 | 0.040 |
Why?
|
| Rats | 2 | 2000 | 1545 | 0.040 |
Why?
|
| Myenteric Plexus | 1 | 1996 | 1 | 0.030 |
Why?
|
| NADPH Dehydrogenase | 1 | 1996 | 4 | 0.030 |
Why?
|
| Calmodulin | 1 | 1996 | 9 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 1996 | 3 | 0.030 |
Why?
|
| Apoptosis | 1 | 2000 | 739 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1996 | 40 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1996 | 34 | 0.030 |
Why?
|
| Myoglobin | 1 | 1996 | 32 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1996 | 122 | 0.030 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 1995 | 2 | 0.030 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 1995 | 5 | 0.030 |
Why?
|
| Viral Envelope Proteins | 1 | 1995 | 5 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1996 | 116 | 0.030 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1995 | 44 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 316 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1996 | 305 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2013 | 44 | 0.030 |
Why?
|
| Stents | 1 | 2013 | 113 | 0.030 |
Why?
|
| Female | 3 | 2015 | 14463 | 0.020 |
Why?
|
| Animals | 3 | 2000 | 9960 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 1927 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 2433 | 0.020 |
Why?
|
| Aged | 1 | 2013 | 5167 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 7383 | 0.010 |
Why?
|
| Mitochondrial Swelling | 1 | 2000 | 1 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2000 | 5 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2000 | 5 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 17 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2000 | 19 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2000 | 10 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 15 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2000 | 20 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2000 | 33 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 2000 | 12 | 0.010 |
Why?
|
| Caspases | 1 | 2000 | 43 | 0.010 |
Why?
|
| Permeability | 1 | 2000 | 58 | 0.010 |
Why?
|
| Cell Death | 1 | 2000 | 110 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 310 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 586 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 545 | 0.010 |
Why?
|
| Macaca nemestrina | 1 | 1995 | 1 | 0.010 |
Why?
|
| Proviruses | 1 | 1995 | 2 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1995 | 17 | 0.010 |
Why?
|
| HIV | 1 | 1995 | 11 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1995 | 45 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1995 | 13 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1995 | 47 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1995 | 22 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 130 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 143 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1995 | 53 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 205 | 0.010 |
Why?
|
| Spleen | 1 | 1995 | 109 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1995 | 163 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1995 | 95 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 262 | 0.010 |
Why?
|
| Genotype | 1 | 1995 | 442 | 0.010 |
Why?
|
| Base Sequence | 1 | 1995 | 573 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1995 | 229 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 674 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 1036 | 0.010 |
Why?
|
| Phenotype | 1 | 1995 | 665 | 0.010 |
Why?
|
| Lung | 1 | 1995 | 349 | 0.010 |
Why?
|
| Pregnancy | 1 | 1995 | 1131 | 0.010 |
Why?
|